Journal of Hepatology
Volume 54, Issue 1 , Pages 19-25 , January 2011

Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion

  • Shuang Wu

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • ,
  • Fumio Imazeki

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • Corresponding Author InformationCorresponding author. Address: Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba 260-8670, Japan. Tel.: +81 43 226 2083; fax: +81 43 226 2088.
    • ,
  • Fuat Kurbanov

      Affiliations

    • Department of Virology, Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
    • ,
  • Kenichi Fukai

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • ,
  • Makoto Arai

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • ,
  • Tatsuo Kanda

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • ,
  • Yutaka Yonemitsu

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
    • ,
  • Yasuhito Tanaka

      Affiliations

    • Department of Virology, Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
    • ,
  • Masashi Mizokami

      Affiliations

    • Research Center for Hepatitis and Immunology, International Medical Center of Japan Kounodai Hospital, Ichikawa, Japan
    • ,
  • Osamu Yokosuka

      Affiliations

    • Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan

Received 15 December 2009 ,Revised 4 June 2010 ,Accepted 7 June 2010.

References 

  1. Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Annu Rev Microbiol. 1997;51:151–178
  2. Arataki K, Kumada H, Toyota K, Ohishi W, Takahashi S, Tazuma S, et al. Evolution of hepatitis C virus quasispecies during ribavirin and interferon-alpha-2b combination therapy and interferon-alpha-2b monotherapy. Intervirology. 2006;49:352–361
  3. Laskus T, Wilkinson J, Gallegos-Orozco JF, Radkowski M, Adair DM, Nowicki M, et al. Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. Gastroenterology. 2004;127:764–776
  4. Pawlotsky JM. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis. 2003;7:45–66
  5. Pellerin M, Lopez-Aguirre Y, Penin F, Dhumeaux D, Pawlotsky JM. Hepatitis C virus quasispecies variability modulates nonstructural protein 5A transcriptional activation, pointing to cellular compartmentalization of virus–host interactions. J Virol. 2004;78:4617–4627
  6. Fan X, Mao Q, Zhou D, Lu Y, Xing J, Xu Y, et al. High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy. Hepatology. 2009;50:1765–1772
  7. da Silva J. The evolutionary adaptation of HIV-1 to specific immunity. Curr HIV Res. 2003;1:363–371
  8. Edwards CT, Holmes EC, Pybus OG, Wilson DJ, Viscidi RP, Abrams EJ, et al. Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection. Genetics. 2006;174:1441–1453
  9. Lipsitch M, O’Hagan JJ. Patterns of antigenic diversity and the mechanisms that maintain them. J R Soc Interface. 2007;4:787–802
  10. Ross HA, Rodrigo AG. Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration. J Virol. 2002;76:11715–11720
  11. Villet S, Pichoud C, Villeneuve JP, Trepo C, Zoulim F. Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient. Gastroenterology. 2006;131:1253–1261
  12. Yim HJ, Hussain M, Liu Y, Wong SN, Fung SK, Lok AS. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology. 2006;44:703–712
  13. Bertoletti A, Maini M, Williams R. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res. 2003;60:61–66
  14. Huang CF, Lin SS, Ho YC, Chen FL, Yang CC. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol. 2006;3:97–106
  15. Panther E, Spangenberg HC, Neumann-Haefelin C, Rosler K, Blum HE, von Weizsacker F, et al. The role of the virus specific T-cell response in acute and chronic HBV and HCV infection. Z Gastroenterol. 2004;42:39–46
  16. Tan AT, Koh S, Goh V, Bertoletti A. Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective. J Gastroenterol Hepatol. 2008;23:833–843
  17. Bruss V, Gerlich WH. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology. 1988;163:268–275
  18. Garcia PD, Ou JH, Rutter WJ, Walter P. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol. 1988;106:1093–1104
  19. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet. 1989;2:588–591
  20. Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 1994;68:8102–8110
  21. Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Meth. 1999;80:97–112
  22. Simmonds P. Recombination and selection in the evolution of picornaviruses and other Mammalian positive-stranded RNA viruses. J Virol. 2006;80:11124–11140
  23. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–1599
  24. Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk GY. Molecular evolution of hepatitis B virus over 25 years. J Virol. 2006;80:10307–10314
  25. Bozkaya H, Ayola B, Lok AS. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology. 1996;24:32–37
  26. Hannoun C, Horal P, Lindh M. Long-term mutation rates in the hepatitis B virus genome. J Gen Virol. 2000;81:75–83
  27. Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol. 2001;82:693–712
  28. Fares MA, Holmes EC. A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol. 2002;54:807–814
  29. Locarnini S. Molecular virology and the development of resistant mutants: implications for therapy. Semin Liver Dis. 2005;25(Suppl. 1):9–19
  30. Stumpf MP, Pybus OG. Genetic diversity and models of viral evolution for the hepatitis C virus. FEMS Microbiol Lett. 2002;214:143–152
  31. Lim SG, Cheng Y, Guindon S, Seet BL, Lee LY, Hu P, et al. Viral quasi-species evolution during hepatitis Be antigen seroconversion. Gastroenterology. 2007;133:951–958
  32. Chan HL, Hussain M, Lok AS. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology. 1999;29:976–984
  33. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis. 1999;179:775–782
  34. Blackberg J, Kidd-Ljunggren K. Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe. J Med Virol. 2000;60:107–112
  35. Lindh M, Gustavson C, Mardberg K, Norkrans G, Dhillon AP, Horal P. Mutation of nucleotide 1, 762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers. J Med Virol. 1998;55:185–190
  36. Kim YS, Kim SI, Hwang SG, Kim JO, Cho JY, Lee JS, et al. Diversity of core promoter mutations in immune clearance phase of chronic HBV infection. Eur J Gastroenterol Hepatol. 1999;11:821–825
  37. Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion. J Med Virol. 2004;74:237–245
  38. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002;35:1522–1527
  39. Hui CK, Leung N, Shek TW, Yao H, Lee WK, Lai JY, et al. Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients. Hepatology. 2007;46:690–698
  40. Liaw YF, Chu CM, Su IJ, Huang MJ, Lin DY, Chang-Chien CS. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology. 1983;84:216–219
  41. Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology. 1987;92:1839–1843
  42. Chu CM, Yeh CT, Lee CS, Sheen IS, Liaw YF. Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol. 2002;40:16–21

PII: S0168-8278(10)00708-7

doi: 10.1016/j.jhep.2010.06.018

Journal of Hepatology
Volume 54, Issue 1 , Pages 19-25 , January 2011

Article Tools

* Image Usage & Resolution